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ABSTRACT
Protein phosphatase-1 (PP1) is a key regulator of
transcription and is targeted to promoter regions via
associated proteins. However, the chromatin binding
sites of PP1 have never been studied in a systematic
and genome-wide manner. Methylation-based DamID
profiling in HeLa cells has enabled us to map hun-
dreds of promoter binding sites of PP1 and three
of its major nuclear interactors, i.e. RepoMan, NIPP1
and PNUTS. Our data reveal that the  ,  and  iso-
forms of PP1 largely bind to distinct subsets of pro-
moters and can also be differentiated by their pro-
moter binding pattern. PP1 emerged as the major
promoter-associated isoform and shows an overlap-
ping binding profile with PNUTS at dozens of ac-
tive promoters. Surprisingly, most promoter binding
sites of PP1 are not shared with RepoMan, NIPP1 or
PNUTS, hinting at the existence of additional, largely
unidentified chromatin-targeting subunits. We also
found that PP1 is not required for the global chro-
matin targeting of RepoMan, NIPP1 and PNUTS, but
alters the promoter binding specificity of NIPP1. Our
data disclose an unexpected specificity and com-
plexity in the promoter binding of PP1 isoforms and
their chromatin-targeting subunits.
INTRODUCTION
Protein phosphatase-1 (PP1) is a member of the Phos-
phoProtein Phosphatases (PPP) superfamily of Ser/Thr-
specific protein phosphatases (1,2). Mammalian genomes
harbor three PP1 encoding genes that altogether generate
four isozymes, namely PP1, PP1 and the splice variants
PP11 and PP12. These isoforms mainly differ in their
extremities and have identical enzymatic properties. Except
for PP12, which is only expressed in testis and brain, the
other PP1 isoforms appear to be present in all mammalian
cells. PP1 dephosphorylates hundreds of proteins. Never-
theless, PP1 acts in a highly specific and timely manner be-
cause it forms heterodimeric or heterotrimeric complexes
with ≈200 PP1 interacting proteins (PIPs) that determine
when and where substrates are dephosphorylated. Recent
proteomic data show that the total cellular concentration
of PIPs is much higher than that of PP1 (3,4), indicating
that PIPs are not constitutively associated with PP1 and
compete for binding to the limited cellular pool of PP1.
In general, PIPs are structurally unrelated and mainly bind
to PP1 via short docking motifs (1,2). The most common
PP1-binding sequence is known as the RVxF-motif, which
binds to a hydrophobic channel that is remote from the ac-
tive site and is often essential to anchor PP1 (5–9). Other
PP1 binding motifs restrain the activity of PP1, e.g. by oc-
cluding a substrate binding groove or the active site (6–7,9),
or enhance the activity of PP1 by creating an extended sub-
strate binding site (5). Some PIPs also have a binding re-
gion for the N or C-terminus of PP1, accounting for the
formation of isoform-specific holoenzymes (5). In addition
to their PP1 binding domain, PIPs often also have regions
that directly recruit substrates or mediate the targeting of
PP1 to a specific subcellular location that contains a subset
of substrates (1,8). Finally, some PIPs not only regulate PP1
but are themselves substrates for associated PP1 (1,2).
PP1 has key functions in a variety of cellular processes,
including transcription (10–14). However, a detailed map
of the genes that are regulated by PP1 is not available. Also,
it is often not clear whether transcriptional control is me-
diated by a pool of PP1 that is associated with specific
gene-regulatory elements or is more indirect and involves,
for example, the regulation of the concentration, activity
or recruitment of specific transcription factors. PP1 itself
is not known to bind to DNA or histones, indicating that
its targeting to chromatin is mediated by specific PIPs. The
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quantitatively most important and best characterized nu-
clear PIPs are NIPP1, PNUTS andRepoMan, which are all
three (partially) associated with chromatin (10,12–13,15–
22). NIPP1 has been implicated in the silencing of genes
via the histone metyltransferase EZH2 (12,13) and the reg-
ulation of pre-mRNA splicing (23). PNUTS controls tran-
scription by RNA polymerase II (10,18), but also has a role
in DNA repair (17,24) and the regulation of the transcrip-
tion factors p53 and Rb (25–29). RepoMan has been iden-
tified as a mitotic histone targeting subunit of PP1 and as a
key regulator of the DNA damage response (15–16,21,30).
NIPP1, PNUTS and RepoMan have an RVxF-type PP1
docking motif and mutation of this motif abolishes their
binding to PP1, which can be used as a tool to dissect the
role of associated PP1.
The two major techniques that are currently used for the
mapping of chromatin binding sites of a protein of inter-
est (POI) are chromatin immunoprecipitation (ChIP) and
DNA adenine methyltransferase identification (DamID)
(31–36). ChIP involves the immunoprecipitation of a POI
after its covalent crosslinking to chromatin and shearing of
the DNA in ≈500 bp fragments. DamID identifies chro-
matin interaction sites by mapping adenines in a GATC
context that are methylated by the bacterial methyltrans-
feraseDam,which is targeted to specific loci by a fused POI.
The co-immunoprecipitated DNA (ChIP) or methylated
DNA fragments (DamID) can be identified using DNAmi-
croarray technology. ChIP has the advantage that it maps
chromatin-binding sites of endogenous proteins. However,
it is dependent on the availability of antibodies and suf-
fers from artifacts generated by crosslinking. DamID is
antibody-independent and, hence, not limited by epitope-
masking in multisubunit complexes like PP1 holoenzymes.
Another advantage of DamID is that it samples chromatin
binding over a prolonged time, enabling its use for signaling
proteins like PP1 that only transiently interact with chro-
matin. Disadvantages of DamID are that it is somewhat
less sensitive than ChIP, requires the generation of stable
cell lines and maps chromatin binding of trace amounts of
an ectopically expressed fusion protein. However, the latter
can also be an advantage as it enables a comparison between
a wild-type (WT) and mutant POI.
We have used DamID for the genome-wide mapping of
the promoter binding sites of PP1 isoforms and three nu-
clear PIPs inHeLa cells. In addition, we compared the bind-
ing sites of both WT PIPs and their PP1-binding mutants.
Our profiling identified hundreds of promoter-binding sites
of PP1 and provided insights into the specificity of the chro-
matin targeting of the PP1 isoforms and their crosstalk with
PIPs.
MATERIALS AND METHODS
Plasmids and antibodies
Full-length rabbit PP1, rabbit PP1, rat PP11, human
PNUTS, bovine NIPP1 and human RepoMan were cloned
into the pIND-(V5)-EcoDam vector using the InFusion
HD cloning system (Clontech), after removal of the V5-
tag. The InFusion system was also adopted for the cloning
of NIPP1, PNUTS and RepoMan into the eGFP-N1 vec-
tor to generate EGFP-tagged fusion proteins. Antibod-
ies against RNA polymerase II pS2 (pol II-pS2; ab5131),
TATA binding protein (TBP; ab51841) and Green Fluo-
rescent Protein (GFP, ChIP grade, ab290) were purchased
fromAbcam (Cambridge, UK). Anti-PP1 (SC-6107, clone
C-19), PP1 (SC-6104, clone N-19), PP1 (SC-6108, clone
C-19), EGFP (SC-8334) and histone H3 (SC-10809) were
obtained from Santa-Cruz (Dallas, USA). Alpha tubulin
(T6074, clone B-5–1–2) and histone H3 (h0163) antibod-
ies were delivered by Sigma-Aldrich (Saint Louis, USA).
Dam antibody was purchased from Acris (AM05338PU-
N). The following antibodies were homemade: anti-NIPP1,
anti-PP1 (13) and anti-PNUTS (37). A synthetic peptide
comprising amino acids 581–599 of RepoMan coupled to
keyhole limpet haemocyanin was used to generate a rabbit
polyclonal antibody. The anti-RepoMan antibodies were
affinity-purified on the peptide coupled to bovine serum al-
bumin (BSA) and linked to CNBr-activated Sepharose 4B
(GE Healthcare, Buckinghamshire, UK).
Cell culture, fractionation and immunoprecipitations
HeLa cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) Low glucose (1 g/l) Glutamax growth
medium, supplemented with 10% Fetal Calf Serum (FCS)
(Sigma-Aldrich), 100 U/ml penicillin and 100 g/ml strep-
tomycin. HEK293T cells were cultured in DMEM High
glucose (4.5 g/l) Glutamax with the same supplements.
Transfection with plasmid DNA was performed using Fu-
GENE 6 HD transfection reagent (Roche, Basel, Switzer-
land) or Genius DNA Transfection Reagent (Westburg,
Leusden, The Netherlands). HEK293T cells were grown in
150 mm plates until confluency and then harvested.
Cytoplasmic and nucleoplasmic fractions were obtained
as previously described (38). The chromatin fraction was
incubated for 30 min at 37◦C in 500 l nuclease buffer
(50 mM Tris/HCl at pH 8, 1.5 mM CaCl2, 25 mM NaF)
with 60 units of micrococcal nuclease. The sample was cen-
trifuged for 2 min at 700 x g and the supernatant was
used as the ‘soluble’ chromatin fraction. The pellet was
dissolved in the same volume of sodium dodecyl sulphate
(SDS) sample buffer and used as ‘insoluble’ fraction. Equal
volumes of each fraction were loaded on a 10% sodium
dodecylsulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) gel and stained by immunoblotting for PP1, PP1,
PP1 , TBP, alpha tubulin and histone H3.
SiRNA duplexes against human PP1 (CC
GCAUCUAUGGUUUCUACdTdT), PP1
(UUAUGAGACCUACUGAUGUdTdT), PP1
(GCAUGAUUUGGAUCUUAUAdTdT), PNUTS
(CGAGUAAAUGUGAAUAAGA/GCAGACCCGUUC
ACCAGAA/GCAAUAGUCAGGAGCGAUA/GCUA
CAAACUUCUUAACAA), control PP1 (D-001210–02)
and control PNUTS (D-001206–13) were obtained from
Dharmacon (Chicago, IL, USA). Knockdowns were
performed using Genius DNA Transfection Reagent
(Westburg) for the PP1 isoforms and DharmaFECT Duo
Transfection Reagent (Dharmacon) for PNUTS, and were
analyzed after 36 or 16 h, respectively. For cell fractiona-
tion after the knockdown of PP1 the micrococcal nuclease
treatment was omitted and the chromatin fraction was
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solubilized by sonication for 15 min at 0◦C in SDS lysis
buffer (38).
EGFP-traps were performed as described previously
(12,13). In short, the soluble pool of chromatin-enriched
fractions was obtained as described above and the lysates
were incubated overnight at 4◦C with 25l of EGFP-trap
beads (1:1 suspension, Chromotek, Planegg-Martinsried,
Germany). The beads were spun down for 30 s at 500 x
g at 4◦C and washed five times with 20 mM Tris/HCl at
pH 7.5 plus 0.3 M NaCl. Finally, the pellets were boiled in
SDS sample buffer and processed for immunoblotting with
EGFP antibodies. Immunoblots were visualized with eCL
reagent (PerkinElmer, Waltham, USA) in an ImageQuant
LAS4000 imaging system (GE Healthcare) and were quan-
tified using ImageQuant TL software (GE Healthcare).
Immunostaining
For immunofluorescence studies of the localization of the
Dam-fusions, HeLa cells were grown on poly-lysine coated
coverslips in a 24-well chamber and co-transfected with
the pIND-(V5)-EcoDam-PP1 isoforms or the pIND-(V5)-
EcoDam-PIP-WT/M vectors and the pVgRXR plasmid
encoding the Ecdysone and Retinoic X receptors (Invit-
rogen, Waltham, USA). Twenty hours post transfection,
2 M of Ponasterone A (Invitrogen) was added and 24
h later, the cells were treated for 4 min at 4◦C with ice
cold CSK buffer (100 mM NaCl, 300 mM sucrose, 3 mM
MgCl2, 10 mM PIPES at pH 6.8) supplemented with 0.2%
Triton X-100. Subsequently, the cells were fixed with 4%
paraformaldehyde, permeabilized with 0.5% Triton X-100,
blocked in 3% BSA-PBS and incubated first overnight in
1% BSA-PBS with the primary Dam antibody and then
with Horseradish peroxidase (HRP)-conjugated secondary
anti-mouse antibody for 2 h. The HRP signal was enhanced
by using the TSA-Plus Fluorescien System (PerkinElmer).
DNAwas stainedwithDAPI. The cells were visualized with
a Leica TCS SPE laser-scanning confocal system mounted
on a Leica DMI 4000B microscope, equipped with a Leica
ACS APO 40× 1.30NA oil objective.
ChIP and quantitative RT-PCR
ChIP assays were performed as described in (12). Total
RNA was isolated using TRIzol R© Reagent (Life tech-
nologies, Carlsbad, USA) according to the manufacturers’
guidelines. Remnant genomic DNA was removed using
the TURBO DNA-freeTM Kit (Life technologies). RNA
(1–2g) was reverse-transcribed with Random Hex-
amer Primer (Thermo Scientific, Waltham, USA) and
oligo dT primer (Sigma-Aldrich) using the RevertAid
Premium Reverse Transcriptase and RiboLock RNase
inhibitor enzymes (Fermentas, Waltham, USA). About
1.2% of the cDNA was PCR-amplified in duplicate,
using SYBR Green qPCR Mix (Invitrogen) and a Ro-
torgene detection system (Corbett Research, Cambridge,
UK), as described by Nuytten et al. (39). Quantita-
tive reverse transcriptase polymerase chain reation
(PCR) was performed to check the transcript levels of
PP1 (5′-CGAGTTTGATAATGCTGGTGGAATG-
3′ and 5′-GCTGTTCGAGTTGGAGTGAC-3′),
PNUTS (5′-TCCTCATGAGCCTGATCCT-3′ and 5′-
GTCTCAACATACGGAGTCTCATC-3′), SNORD24
(5′-AGAATATTTGCTATCTGAGAGATGGTG-3′
and 5′-TGCATCAGCGATCTTGGT-3′), SNORD28
(5′-TTGATAAGCTGATGTTCTGTGAGG-3′ and 5′-
TGCCATCAGAACTCTAACATGC-3′), SNORD33
(5′-TCCCACTCACATTCGAGTTTC-3′ and 5′-
CCTCAGATGGTAGTGCATGTG-3′) and HIST1H3D
(5′-CGCAGGACTTCAAGACTGAT-3′ and 5′-
TAGGTTGGTGTCCTCAAACAG-3′). Data were
normalized against the housekeeping gene HPRT
(5′-TGACACTGGCAAAACAATGCA-3′ and 5‘-
GGTCCTTTCACCAGCAAGCT-3′).
DamID profiling
DamID was performed as described in (31). Briefly, stable
polyclonal HeLa cell lines were generated using constructs
cloned into the pIND-(V5)-EcoDam vector to express trace
amounts of Dam or C-terminal fusions with PP1, PP1,
PP11, PNUTS, NIPP1 or RepoMan due to leakiness from
the uninduced promoter. Cell lines were generated for both
theWTPIPs and their PP1-bindingmutants (M). Two inde-
pendent stable cell lines were generated for each construct.
Expression of Dam or its fusion proteins leads to methy-
lation of genomic DNA at sites of the fusion proteins’ as-
sociation with chromatin. Genomic DNA is extracted and
processed by methylation-sensitive restriction digests and
linker dependent PCR amplification, followed by microar-
ray detection of enriched fragments. To verify the isolated
methylated DNA, the PCR-amplified fragments were run
on a 2% agarose gel (Supplementary Figure S2).
For DamID it is crucial that only trace amounts of
Dam or its fusion proteins are expressed, which cannot be
detected by immunoblotting. To verify the expression of
the full-length Dam-fusion proteins, HeLa cells were co-
transfected with the pIND-(V5)-EcoDam-PP1 isoforms or
the pIND-(V5)-EcoDam-PIP-WT/Mvectors and the pVg-
RXR plasmid encoding the Ecdysone and Retinoid-X re-
ceptors as inducible heterodimers that bind to the Ecdysone
response element in the pIND vector (Invitrogen). Twenty
hours post transfection, 2 M of the Ecdysone analogue
Ponasterone A (Invitrogen) was added and the cells were
harvested 24 h later. Cells were lysed in a buffer containing
20mMTris/HCl at pH7.5, 0.3MNaCl, 0.5%TritonX-100,
25 mM NaF, 1 mM Vanadate, 1 mM PMSF, 1 mM benza-
midine and 5 M leupeptin for 20 min on ice. The lysates
were clarified by centrifugation (10 min at 1700 g) and SDS
sample bufferwas added to the supernatant. Equal amounts
(40g)were loaded on a 10%SDS-PAGEgel and stained by
immunoblotting for endogenous proteins and Dam-fusions
with antibodies against the endogenous proteins.
Computational analysis
Tiling-array handling, quality control and preliminary
analysis were performed by the VIB MicroArray Facility
(www.microarrays.be), as described in (12). In brief, for the
genome-wide interaction site profiling, the DamID-DNA
was labeled and hybridized to a GeneChip Human Pro-
moter 1.0R Array (Affymetrix, Santa Clara, CA, USA).
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The tiling array readouts were analyzed with the ‘model-
based analysis of tiling arrays’ (MAT) algorithm (version
1.0.0) against the human reference genome (hg19) (40). We
normalized the datasets obtained from two independent
polyclonal cell lines of eachDam-fusion over twoDam-only
datasets. Each dataset consisted of three technical repeats of
the same cell line pooled together prior to hybridization to
the tiling array in order to reduce possible artifacts. The sig-
nificant binding peaks at −2/+2 kb relative to all currently
annotated transcription start sites (TSS) were selected us-
ing a threshold for significance that was set at a P-value of
1 × 10−3–5, depending on the dataset. The resulting set of
78 828 TSSs was derived fromUCSCGenes (KnownGenes;
Feb. 2009; hg19,GRCh37).Multiple TSSs for one genewere
filtered as described in (41). Briefly, if a gene had multiple
TSSs assigned to it, we analyzed the RNA Polymerase II
signal intensity for a region of 4 kb at either site of the TSS
and selected the TSS that was linked to the highest RNA
polymerase II signal. This yielded the final list of ∼25 000
TSSs. Further analysis on the significant binding sites was
performed using tools linked to the Cistrome-galaxy web-
site (42). All datasets used are available at GEO under the
accession number GSE54170.
We created a reference profile of the PP1 isoforms and
PIPs by calculating the average signal profile across all pre-
viously defined promoter regions, i.e. 2 kb at either side of
the TSS, using a window size of 20 bp. The obtained refer-
ence list was used to normalize the DamID profiles across
their respective genome binding sites within these regions.
This strategy was also used to normalize the histone modi-
fication ChIP-Seq signal profiles obtained from the UCSC
Genome browser (hg19, GRCh37). The average signal pro-
files were obtained and calculated using the SitePro module
of the CEAS package (43). The correlation analyses per-
formed on the DamID datasets and the ENCODE datasets
made use of the general correlation tool present on the
Cistrome-galaxy portal (42). In addition to the correlation
analysis, we also performed co-association analysis using
the Genome Structure Correction (GCS) tool (44). Gene
Ontology analysis was carried out using DAVID (45). Re-
dundant terms were filtered out and then summarized uti-
lizing the REVIGO tool (46).
Confocal microscopy
The cells were visualized with a Leica TCS SPE laser-
scanning confocal system mounted on a Leica DMI 4000B
microscope, equipped with a Leica ACS APO 63X 1.30NA
oil DIC objective. Z-stacks of 1 m per slice were made
of HeLa cells expressing WT or mutant versions of
EGFP-PNUTS, EGFP-NIPP1 or EGFP-RepoMan, and
immunostained for Pol II-pS2. Immunostainings of TATA-
binding Protein (TBP) and alpha tubulin were used as pos-
itive and negative controls, respectively. The co-localization
analysis was performed on each Z-stack using the ImageJ
plugin Just Another Co-localization Plugin (JACoP) (47),
at an image pixel size of 512 × 512. Pearson’s Correlation
Coefficients (PCCs) were calculated using Costes automatic
threshold (48). We have opted for the PCC as this allowed
for the co-localization analysis results to be more easily
compared to the bioinformatical screening of the DamID
versus Encode data, which are also given as correlation co-
efficients. The Costes automatic threshold function in the
JaCoP plugin also gives this as a standard output. We used
Costes automatic threshold as this is more accurate in pre-
dicting the background level of fluorescence in both chan-
nels. It is also more suitable for high-throughput analysis
since the threshold has not to be set manually.
RESULTS
Mapping of the promoter-binding sites of PP1
To identify the isoforms of PP1 that are associated with
chromatin, HeLa (Figure 1A) and HEK293T cell lysates
(Supplementary Figure S1) were fractionated by differential
centrifugation. Histone H3 (H3) and TATA-binding pro-
tein (TBP) served as markers for the chromatin-enriched
fractions and tubulin was used as a cytoplasmic marker. All
three PP1 isoforms, as visualized by immunoblotting with
previously validated isoform-specific antibodies (30), were
detected in both the cytoplasmic and chromatin-enriched
fractions. PP1 was roughly equally distributed between the
‘soluble’ chromatin fraction, obtained by a nuclease pre-
treatment and the remaining ‘insoluble’ fraction, which also
comprises nucleoskeletal elements. These data demonstrate
that a substantial fraction of PP1, PP1 and PP1 is asso-
ciated with chromatin, consistent with previous immunolo-
calization data in various cell types (49–51) and the estab-
lished function of PP1 in transcriptional regulation (10–
13,18,52).
To gain genome-wide information on the promoter bind-
ing sites of PP1, we adopted the DamID technique, in par-
ticular because this technique is antibody independent and
also detects transient interactions (Figure 1B). First, the
expression of the fusion constructs in HeLa cells was ver-
ified by their transient co-overexpression with the activa-
tor plasmid pVgRXR in the presence of the Ecdysone ana-
logue Ponasterone A (Figure 1C). We also verified that the
Dam-PP1 fusions were (partially) targeted to the nucleus
(Figure 1D), consistent with the localization of endoge-
nous PP1 isoforms (14). Also, PP1 was excluded from the
nucleoli, unlike the other PP1 isoforms. Next, HeLa cell
lines were generated that stably express trace amounts of
Dam, Dam-PP1, Dam-PP1 or Dam-PP11 due to leak-
iness from an uninduced promoter (Supplementary Figure
S2). To rule out effects from the random integration of the
transgenes, two distinct polyclonal cell lines were generated
and analyzed for each construct. From each cell line, three
independent genomic samples were isolated and adenine-
methylated DNA fragments were prepared, PCR ampli-
fied, pooled and hybridized to GenChip Human Promotor
1.0R Arrays (Affymetrix), covering the −7.5/2.5 kb region
of ≈25 000 TSS. Using the default threshold of the MAT
peak-calling tool we identified 94, 620 and 519 significant
promoter-binding peaks for PP1, PP1 and PP1 , respec-
tively (Figure 1E). For these analyses the promoter region
was defined as −2 kb/+2kb relative to the TSS. The peaks
of PP1 and PP1 showed a moderate overlap (19%), but
there was only a weak overlap (<10%) between the peaks
of PP1 and the other isoforms. This (lack of) overlap was
also confirmed by the signal profiles (53) of the significant
binding sites (Figure 1F, Supplementary Figure S3). Thus,
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Figure 1. PP1 isoforms bind to distinct promoter subsets. (A) HeLa cells were fractionated by differential centrifugation into cytoplasmic, nucleoplasmic
as well as nuclease-solubilized (soluble) and insoluble fractions. All fractions were diluted to the same volume and processed for immunoblotting with
isoform-specific PP1 antibodies. TATA-binding protein, -tubulin and histone H3 served as markers. The left panel shows a representative blot. The right
panel shows the average of scans± S.E.M. of four independent experiments. The protein levels are given as percentages of the total protein pool. (B) Fusions
of Dam and PP1 that are targeted to specific chromatin regions methylate flanking adenines in a GATC sequence, which can be mapped using methylation
(un)specific restriction enzymes, PCR-amplification and DNA microarray analysis. (C) Expression of the Dam-PP1 fusions after their transient induction
with Ponasterone A in HeLa cells. (D) Subcellular localization of the Ponasterone-A induced Dam-PP1 fusions in HeLa cells. (E) Venn diagram showing
the significant binding peaks and overlapping peaks of each PP1 isoform on the promoter regions. The area of the circles and overlaps correlates with the
number of peaks. In the majority of cases one peak translates to one promoter but multiple peaks can also occupy a single promoter. (F) Global signal
profiles of the PP1 isoforms at −2/+2 kb of the peak centers. The percentages of the PP1 signals were calculated according to the highest signal found
across the binding sites. The graphs were drawn using the R package ggplot2 (53). (G) The average raw signal profile of the PP1 isoforms on promoter
regions, as calculated with the SitePro tool from the CEAS package (43). (H) Circos plot (version 0.61) of the significant PP1 promoter binding peaks
across the HeLa genome (54). The line profiles of the PP1 isoforms reflect the intensity of the isoform binding signals. The lines underneath the line profiles
denote the position of the significant binding sites.
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although there was some overlap between the binding sites
of PP1 and PP1 , the PP1 isoforms generally bound to
distinct loci, hinting at isoform-specific functions.
We also performed promoter profile analyses of the
raw signals, which reflect the average binding propensity
of the Dam fusions (54). Remarkably, the three PP1 iso-
forms showed a distinct signal-binding pattern across the
TSS region (Figure 1G). The Dam-PP1 signals were low
and largely confined to the vicinity of the TSS. However,
the Dam-PP1 signals were more prominent and spread
across the entire promoter region. The Dam-PP1 sig-
nals were strong and showed a bimodal distribution, with
peaks flanking the TSS. Thus, all three PP1 isoforms bind
to chromatin but PP1 is quantitatively the most impor-
tant promoter binding isoform. Finally, we have analyzed
the genome-wide distribution of the PP1 binding sites and
found that the three isoforms are associated with all chro-
mosomes (Figure 1H).
Mapping of the promoter-binding sites of nuclear PIPs
The major mammalian nuclear PIPs are NIPP1, PNUTS
and RepoMan (10,12–13,15–18,24). All three have an
RVxF-type PP1 docking site (Figure 2A) and are partially
chromatin-associated. To map the promoter-binding sites
of these PIPs byDamID,we generated stableHeLa cell lines
expressing fusions of Dam and NIPP1, PNUTS or Repo-
Man (Supplementary Figure S2). The expression, subcel-
lular localization and PP1 binding of the DamID fusion
constructs was first validated after their transient induction
with Ponasterone A (Supplementary Figure S4). All fusions
were nuclear and the NIPP1 fusions were enriched at the
nuclear speckles, as previously already shown for endoge-
nous NIPP1 (55). The promoter binding sites were mapped
and analyzed as detailed above for the PP1 isoforms. We
identified 941, 599 and 330 significant binding peaks for
PNUTS-WT, NIPP1-WT and RepoMan-WT, respectively
(Figure 2B). The overlaps between the significant binding
sites of these PIPs were limited, which was confirmed by the
signal profiles of the three PIPs at the PNUTS, NIPP1 and
RepoMan promoter binding sites (Figure 2C). The average
promoter binding patterns of the PIPs were also strikingly
different (Figure 2D). RepoMan showed a relatively weak
binding close to the TSS. The binding of NIPP1 was weak
and diffuse. However, PNUTS interacted strongly with the
promoter and showed a bimodal distribution with the low-
est interaction around the TSS. As was the case for the
PP1 isoforms, all three targeting subunits had chromosome-
binding sites distributed across the entire genome (Figure
2E). Finally, some of the identified DamID targets, namely
5 SNORD target sequences for PNUTS (see below) as well
as RPS6KC1 and ATF3 for NIPP1-WT were validated by
ChIP (39).
The promoter binding of NIPP1 is regulated by PP1
Mutation of the RVxF-motif (RVxF→RAxA) of PNUTS,
NIPP1 or RepoMan abolished their binding to PP1 (Sup-
plementary Figure S4C). To examine the dependency of the
promoter binding of these PIPs on associated PP1, we com-
pared the DamID profiles of the Dam-PIP-WT fusions and
the corresponding PP1-binding mutants (M). For PNUTS-
M the number of significant binding sites was about three
times lower than that of PNUTS-WT (313 versus 941; Fig-
ure 3A, left panel). However, the percentage of overlapping
binding sites between the two fusions was very high (79%).
We also computed the DamID signals within a region of 2
kb at either side of the midpoint peaks at both the PNUTS-
WT and PNUTS-M binding sites. The signals were normal-
ized to the highest value, which was set at 100%. We found
that the average signal profiles and strengths of PNUTS-
WT and PNUTS-M were virtually identical at the interac-
tion sites of either theWT orMproteins (Figure 3A,middle
panel), suggesting similar promoter-binding of the WT and
M proteins. This was also evident from signal profiles at in-
dividual promoter regions (Figure 3A, right panel). Taken
together, these data indicate that PP1 is not essential for the
promoter targeting of PNUTS.
The percentage of overlapping binding sites for NIPP1-
WT and NIPP1-M only amounted to 20%, indicating that
PP1 affects the promoter binding specificity of NIPP1 (Fig-
ure 3B, left panel). Consistent with this notion, the sig-
nal strength of NIPP1-WT dropped to background levels
at the interaction sites of NIPP1-M and vice versa (Fig-
ure 3B, middle and right panels). This agrees with previous
data showing that NIPP1-WT and NIPP1-M bind to dis-
tinct chromatin loci (12,13). The promoter binding sites of
RepoMan-WT and RepoMan-M also showed a consider-
able overlap (42%) (Figure 3C, left panel). The average sig-
nal profiles and strengths of RepoMan-WT and RepoMan-
M were similar at the interaction sites of either the WT or
M proteins (Figure 3C, middle and right panels). Thus, PP1
does not appear to be required for the promoter targeting of
RepoMan, in accordance with a recent study showing that
the histone binding of RepoMan in mid-mitosis is PP1 in-
dependent (15,56).
Next, we calculated the co-association between the sig-
nificant binding sites of theWT PIPs and their PP1-binding
mutants (Figure 3D). These calculations were based on the
block bootstrap.py script created by the ENCODE consor-
tium (44) and compared the proximity of the binding sites
of both proteins against the entire genome. The output is a
Z-score, which is a measure of co-association. This analy-
sis confirmed a strong link for both RepoMan and PNUTS
between the WT proteins and their respective PP1-binding
mutants. In contrast, NIPP1-WT correlated only weakly
with NIPP1-M. A similar conclusion was drawn from the
correlation co-efficients (r) of the raw signal profiles be-
tween theWTandMversions of the targeting proteins (Fig-
ure 3E). Collectively, these data confirm that NIPP1-WT
and NIPP1-M largely bind to distinct loci. This contrasts
with PNUTS and RepoMan where the WT andM variants
occupy similar loci.
To validate our findings by an independent biochemical
approach, we examined the effect of a knockdownof PP1 on
the association of PNUTS, RepoMan and NIPP1 with the
chromatin-enriched fraction (Supplementary Figure S5).
The knockdown of PP1 did not affect the global association
of these PIPswith chromatin. These data are consistent with
our DamID data, in that they demonstrate that the global
targeting of the examined PIPs is PP1-independent. At the
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Figure 2. Promoter binding sites of nuclear PIPs. (A) Domain structure of the studied PIPs. (B) Venn diagram showing the significant and overlapping
binding peaks of each PIP-WT on the promoter regions. The areas of the circles and overlaps are correlated to the number of peaks. (C) Global signal
profiles of the PIPs-WT at −2/+2 kb of the peak centers. The percentages of the PIP-WT signals were calculated according to the highest signal found
across the binding sites. The graphs were drawn using the R package ggplot2 (53). (D) The average raw signal profiles of the WT PIPs across all defined
promoter regions. (E) Circos plot of the significant promoter binding peaks across the HeLa genome (54). The line profiles of the PIPs indicate the intensity
of the PIP binding signal across their significant binding sites. The highlights underneath denote the position of the significant binding sites.
same time, these data do not contradict our conclusion that
PP1 regulates the promoter binding specificity of NIPP1.
Identification of promoter-associated PP1 holoenzymes
Tofind outwhether PP1 isoforms co-localizewith the exam-
ined PIPs, we determined the number of overlapping pro-
moter binding sites. Importantly, the majority of PP1 in-
teraction sites were not shared with any of the three exam-
ined PIPs (Figures 1F and 4A), pointing to an involvement
of other, hitherto unidentified promoter-targeting subunits.
However, we noted a striking overlap of 188 binding sites
between PNUTS-WT and PP1 (Figure 4A), in accordance
with a similar average signal profile of both proteins at the
promoter region (Figures 1G and 2D). PNUTS-WT and
PP1 also shared 94 binding sites (Figure 4A), which is
consistent with the overlap between the binding peaks of
PP1 and PP1 (Figure 1F). The co-localization of PP1
with PNUTS was observed at individual promoters (Sup-
plementary Figure S6) as well as genome-wide in a Cir-
cos plot (Figure 4B). In contrast to PNUTS, RepoMan
only had a handful of binding sites in common with PP1
isoforms (Figure 4A and B), in accordance with its PP1-
independent chromatin targeting mechanism. The number
of overlapping binding sites between NIPP1-WT and PP1
isoforms was intermediate to those of PNUTS and Repo-
Man (Figure 4A and B).
To further explore the isoform binding specificity of the
PIPs, we performed co-association and correlation analyses
of both sets of proteins (Figure 4C and D). A clear associa-
tion emerged between the binding sites of PNUTS-WT and
PP1, but not between the binding sites of the PP1 isoforms
and either RepoMan-WT or NIPP1-WT. Taken together,
our data show that (i) PP1 and PNUTS share many bind-
ing sites, (ii) RepoMan and PP1 bind to distinct loci and (iii)
PP1 has numerous binding sites that are not shared by the
examined PIPs.
5778 Nucleic Acids Research, 2015, Vol. 43, No. 12
Figure 3. PP1 dependency of the promoter binding of PNUTS, NIPP1 and RepoMan. (A) Venn diagrams representing the overlap of the significant
promoter binding peaks between PNUTS-WT and PNUTS-M (left panel). Global signal profiles of PNUTS-WT and PNUTS-M across each others’
binding sites (middle panel). The percentages of the signals were calculated according to the highest signal found across each binding site. A representative
peak profile was obtained using the Integrated Genome Browser (IGB 7.0.1), showing the significant peak overlap of PNUTS-WT and PNUTS-M (right
panel). The peak profiles for PNUTS-WT and PNUTS-M are on the same scale and the graphs were drawn using the R package ggplot2 (53). (B) Signal
profiles for NIPP1-WT and NIPP1-M, as detailed for panel A. (C) Signal profiles for RepoMan-WT and RepoMan-M, as detailed for panel A. (D)
Co-association analysis between the significant binding sites of the WT and M variants of the PIPs. Both the color and numbers indicate the Z-score.
The binding sites were subjected to genome structure correction and only the promoter regions were used in the analysis (44). NS, not significant (P >
0.001). (E) Correlation analysis between the signal profiles of the R-subunits across the promoter regions. Both the color and the number indicate the
correlation co-efficient (r). The correlation co-efficients were calculated using the ‘Multiple wiggle files correlation in given regions (version 1.0.0)‘ on the
Cistrome-Galaxy portal (42).
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Figure 4. The promoter localization of PNUTS and PP1 are linked. (A) Table showing the overlap of significant promoter binding sites between the PP1
isoforms and PIPs as well as the total number of peaks for each protein overlapping with the PIPs, in the case of the PP1 isoforms, or the PP1 isoforms, in
the case of the PIPs. Total number of binding sites are given in brackets next to the protein’s name The overlaps were obtained using tools available on the
Cistrome webportal (42). (B) Circos plot showing the interactions between the PP1 isoforms and the nuclear PIPs (54). The ‘chromosomes’ consists of all
the binding sites of the particular Dam-fusion protein stitched together. The size of the chromosomes is therefore directly correlated with the amount and
size of the binding sites of that particular protein on the promoter regions. Every interaction between the PP1 isoforms and PIPs was then mapped onto
these chromosomes and the interactions are shown by links as well as the highlights. The colors correspond to the Dam-fusions making the interaction.
(C) Co-association analysis between the significant binding sites of PP1 isoforms and nuclear PIPs. Both the color and the numbers indicate the Z-score.
The binding sites were subjected to genome structure correction and only the promoter regions were used in the analysis. (D) Correlation analysis between
the signal profiles of the PIPs and PP1 isoforms across the promoter regions. Both the color and the numbers indicate the correlation co-efficient (r).
PP1-PNUTS is associated with RNA Polymerase-II tran-
scribed genes
Next, we examined the nature and activity of the genes that
are associated with the promoter regions that bound PP1
and/or its chromatin-associated PIPs.We first used publicly
available ChIP-Seq datasets of the ENCODE consortium
to calculate the signal correlation of our DamID datasets
across the promoter region with the corresponding histone
modifications and transcription factor (TF) binding sites
(Supplementary Figure S7). The binding sites of PP1 and
PNUTS were at least two-fold enriched for histone modifi-
cations that are associated with actively transcribed genes,
including acetylated (ac) H3K9, H3K27ac and trimethy-
lated (me3) H3K4. For PNUTS this applied to both the
WT and M fusions, consistent with the view that PP1 does
not affect the binding specificity of PNUTS. In contrast, the
promoter-binding sites of RepoMan were not significantly
enriched for any histone mark. Intriguingly, the histone
landscapes of the binding sites of NIPP1-WT and NIPP1-
M were very different, in accordance with their association
with distinct subsets of promoters. Indeed, the NIPP1-M
binding sites were significantly enriched for the activemark-
ersH3K9ac andH3K27ac, but this did not apply toNIPP1-
WT. This agrees with previous findings thatNIPP1-WT, but
not NIPP1-M, regulates gene silencing through recruitment
of the H3K27 methyltransferase EZH2 (13). Nevertheless,
the NIPP1-WT binding sites were not significantly enriched
for H3K27me3, which can be explained by published data
showing that NIPP1-WT only regulates a subset of EZH2
targets (12,13) and also interacts with actively transcribed
genes as a regulator of spliceosome assembly (23). This mul-
tifunctional role of NIPP1 impeded the further characteri-
zation of its gene targets in a genome-wide analysis.
Our analysis also explored correlations between pro-
moter binding sites of PP1, the examined PIPs and various
TFs (Figure 5A). The binding sites of PP1, PP1 , Repo-
Man and NIPP1 did not show a positive correlation with
those of the examined TFs. If anything, the RepoMan bind-
ing sites were negatively correlated with TF binding sites,
consistent with its weak promoter binding activity (Figure
2D) and lack of association with any histone modification
(Supplementary Figure S7). In contrast, the binding sites
of PP1 and PNUTS showed a positive correlation with
most TF binding sites. This applied in particular to Gen-
eral Transcription Factor IIF subunit 1 (GTF2F1; r= 0.42),
Brahma-related gene-1 (BRG1; r= 0.44), RNA polymerase
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Figure 5. A PP1/PNUTS holo-enzyme is associated with elongating RNA Polymerase II. (A) Correlation of the DamID signal profiles on the promoter
regions and the corresponding transcription factor ChIP-Seq datasets from the ENCODE consortium. The correlation co-efficients were calculated using
the ‘Multiple wiggle files correlation in given regions (version 1.0.0)’ found on the Cistrome web portal (42). White boxes indicate non-significant cor-
relations (P > 0.01). (B) Fragment from panel A detailing the correlation coefficients of PP1, PNUTS-WT and PNUTS-M with Pol II-pS2 and other
significant co-associated transcription factors. (C) EGFP-tagged PNUTS-WT or PNUTS-M were transiently expressed in HEK293T cells. EGFP-traps
from the cell lysates were immunoblotted for RNA polymerase II.
II (Pol II; r= 0.40) andRNApolymerase II phosphorylated
at Ser2 of its carboxyterminal domain (Pol II-pS2; r= 0.51)
(Figure 5B). Similar values were obtained for PNUTS-WT
and PNUTS-M. Subcellular localization analysis of pol II-
pS2 and ectopically expressed EGFP-tagged fusions of the
chromatin targeting subunits by confocal fluorescence mi-
croscopy confirmed the co-localization of PNUTS-WT and
PNUTS-Mwith pol II-pS2 (Supplementary Figure S8). For
these experiments TBP and -tubulin were used as positive
and negative controls, respectively. The RepoMan fusion
did not show a significant co-localization with pol II-pS2,
despite its similar diffuse nuclear distribution as PNUTS
and therefore serves as an additional negative control. Fi-
nally, an interaction between PNUTS andRNApolymerase
II was confirmed by co-immunoprecipitation of RNA poly-
merase II with EGFP-PNUTS-WT/M fusions (Figure 5C).
Out of 941 significant promoter-binding sites of PNUTS-
WT (Figure 2B), 782 (83%) overlapped with binding sites
of Pol II-pS2 (Figure 6A). Likewise, 175 out of the 188
PP1-PNUTS holoenzyme-binding sites also bound Pol
II-S2 (not shown), indicating that this PP1 holoenzyme
is almost exclusively associated with the elongating RNA
Polymerase-II complex. On the promoter regions where
PNUTS and Pol II-pS2 had overlapping binding sites,
Pol II-pS2 binding was, on average, four times above the
background level (Figure 6A). These overlapping bind-
ing sites were also enriched for GTF2F1 (two-fold) and
BRG1 (three-fold), two established interactors of RNA
Polymerase II (57,58). Finally, we performed a gene on-
tology (GO) analysis, using the GREAT tool and filtered
for redundant GO terms by REVIGO, to identify the key
processes that are regulated by genes that bind both PP1-
PNUTS and Pol II-pS2 (Figure 6B). For this analysis we
selected 167 genes that reside within 1 kb from the over-
lapping interactor sites (Supplementary Table S1). The
most enriched gene ontology terms were metabolism and
translation/transcription.
Strikingly, the shared set of targeted genes included nu-
merous genes that encode histones or snoRNAs (Supple-
mentary Table S1), including the Small Nucleolar RNA
Host Gene 1 (SNHG1) (Figure 6C), which all generate
transcripts that are not adenylated at the 3′ end. ChIP
experiments confirmed the association of PNUTS-WT/M
with five snoRNA encoding SNORD genes (Supplemen-
tary Figure S9). Also, the knockdown of PNUTS reduced
the expression of the SNORD and the histone encoding
HIST1H3D genes (Figure 7A), whereas the knockdown of
PP1 had the opposite effect (Figure 7B). These data func-
tionally validate the DamID-identified targets of PNUTS
and PP1, and suggest that PP1 is an inhibitor of the tran-
scriptional function of PNUTS.
DISCUSSION
DamID profiling of PP1
ChIP and DamID represent the major prevailing tech-
niques for the mapping of chromatin–protein interaction
sites (31–36). Although they are based on different prin-
ciples, they generate overlapping data when run in paral-
lel (32). The choice for ChIP is to a large extent deter-
mined by the availability of antibodies against an epitope
that is accessible in the context of cross-linked chromatin.
The commercially available isoform-specific anti-PP1 anti-
bodies can be used for immunoblotting but are not of ChIP
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Figure 6. PP1/PNUTS associates with Pol II-pS2. (A) Venn diagram showing binding site overlaps between PNUTS-WT and Pol II-pS2. The normalized
signal profiles of PNUTS-WT, PP1, Pol II-pS2, GTF2F1 and BRG1 across the binding sites of the (non)overlapping subsets are also included. The signal
profiles were normalized using the average background signal of each protein across all the defined promoter regions. (B) Gene Ontology analysis of the
genes that lie within 1 kb of regions where PNUTS-WT and Pol II-pS2 overlap. The analysis was performed using DAVID and the redundant terms were
filtered out using the REVIGO tool (45,46). The bar chart represents the P-values of the enriched GO terms and are displayed as -10Log(p-value). (C)
Representative peak profiles obtained using the Integrated Genome Browser (IGB 7.0.1) showing the overlapping signal profiles of RNA Pol II, Pol II-pS2,
PP1 and PNUTS-WT across the SNHG1 gene. All the signal profiles are to scale.
grade (our unpublished data). Likewise, various commer-
cial or homemade antibodies against NIPP1, PNUTS and
RepoMan are not suited for ChIP experiments (our un-
published data) or give inconsistent results (12). Hence, we
adopted the DamID protocol to map the promoter bind-
ing sites of PP1 isoforms and three major nuclear PIPs. For
these DamID profiling studies we generated 20 stable HeLa
cell lines, i.e. two independent cell lines for Dam and each of
nine examined Dam-fusions. The DamID tool also enabled
us to compare the promoter binding profiles of the WT and
PP1 binding mutants of the examined PIPs.
Our DamID profiling studies identified hundreds of pro-
moter binding sites of PP1 and the examined PIPs (Figures
1E and 2B). Various lines of evidence suggest that the re-
sults are reliable and biologically relevant. Firstly, we noted
a large overlap (79%) between the binding sites of PNUTS-
WT and PNUTS-M (Figure 3A), which can serve as an
excellent illustration of the reproducibility of the DamID
technique. It should be noted that this overlap, if anything,
is underestimated since the binding sites of both PNUTS
variants do not necessarily have to be identical. We also ob-
served a huge overlap between the binding sites of Pol II-
pS2, as mapped by ChIP, either PNUTS (83%) or PP1-
PNUTS (93%) (Figure 6A), as identified by DamID, con-
firming that both profiling techniques generate equivalent
data. Secondly, we obtained very distinct promoter binding
peaks and patterns for the PP1 isoforms, but also for the
examined PIPs, indicating that DamID signals truly reflect
binding affinities and can be detected throughout the pro-
moter region (Figures 1G and 2D). Thirdly, our data are
consistent with data from the literature in that they con-
firm that (i) of all isoforms PP1 is least associated with
chromatin (49), (ii) NIPP1-WT and NIPP1-M have a dis-
tinct chromatin binding specificity (12,13) and (iii) PP1-
PNUTS is linked to RNA pol II on promoter regions (10).
Isoform specificity of the promoter targeting of PP1
In vitro most PIPs, including NIPP1, PNUTS and Repo-
Man, bind to PP1 in an isoform-nonspecific manner, which
is explained by PP1-anchoring motifs, such as the RVxF
motif, that dock to surface grooves that are identical in
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Figure 7. SNORD and HIST1H3D genes are regulated by PNUTS
and PP1 (A) The relative transcript levels of SNORD24, SNORD28,
SNORD33 and HIST1H3D were measured by qRT-PCR in HeLa cells
after knockdownwith control or PNUTS siRNA.HPRTwas used for nor-
malization and data are presented as percentages of the control ± S.E.M.
(n ≥ 3). *, P < 0.05; **, P < 0.01 with the paired Student’s t-test. (B)
The relative transcript levels of SNORD24, SNORD28, SNORD33 and
HIST1H3D were measured by qRT-PCR in HeLa cells after knockdown
with control or PP1 siRNA. HPRT was used for normalization and the
data are presented as percentages of the control ± S.E.M. (n ≥ 3). *, P <
0.05; **, P < 0.01 with the paired Student’s t-test.
all PP1 isoforms (19–21). In intact cells, however, Repo-
Man preferentially interacts with PP1 (21) and NIPP1
with PP1 (22). Our DamID profiling showed that PNUTS
preferentially interacts with PP1 at promoters (Figure
4). Moreover, the observation that the PP1 isoforms have
distinct promoter binding peaks and patterns is consis-
tent with the notion that their targeting to promoters is
largely mediated by different subsets of PIPs. This iso-
form selectivity is likely to be accounted for by isoform-
specific docking motifs, which have already been identi-
fied in some PIPs. For example, the myosin targeting sub-
unitMYPT1 has an ankyrin-repeat domain that specifically
binds to the C-terminus of PP1 (5). Our data indicate that
isoform-specific docking motifs or domains are much more
prevalent than currently appreciated and play a key role in
specifying the function of PP1 isoforms. Presumably, these
isoform-specific docking motifs/domains do not bind with
high affinity to PP1, which explains why they are difficult to
detect in vitro in the presence of other, higher-affinity bind-
ing motifs, but are sufficient to tilt the balance towards the
binding of a specific PP1 isoform in intact cells.
Cross-talk between PP1 and PIPs at promoters
A striking observation was that 73% of the identified PP1
promoter binding sites did not overlap with binding sites of
NIPP1, PNUTS and/or RepoMan, demonstrating that the
targeting of PP1 is largely mediated by other PIPs (Figure
4A andB). This was somewhat unexpected sinceNIPP1 and
PNUTS together bind to a large fraction of PP1 in nuclear
extracts, which did not include, however, the considerable
Figure 8. Model on the role of PP1 in the recruitment of PIPs to promot-
ers. (A) The promoter binding sites of the WT and M-versions of Repo-
Man and PNUTS show a large overlap, indicating that their recruitment is
PP1-independent. (B) NIPP1-WT and NIPP1-M bind to distinct subsets
of promoters, showing that PP1 regulates the binding specificity of NIPP1.
fraction of PP1 that remains associated with chromatin in
the presence of 0.3M NaCl (22). A number of additional
chromatin-associated PIPs have already been identified (2),
and it will be important to delineate their relative contribu-
tion to the promoter targeting of PP1. Conversely, numer-
ous promoter-binding sites of NIPP1, PNUTS and Repo-
Man were not overlapping with PP1 binding sites. This is in
accordance with our conclusion that the global chromatin
targeting of these PIPs is PP1-independent (this work) and
that PIPs exist in a large molar excess to PP1 and hence
compete for binding to the limited pool of PP1 (2).
Our data have provided unexpected insights in the com-
plex cross-talk between PP1 and the examined PIPs at pro-
moters. RepoMan shared very few promoter-binding sites
with PP1 (Figure 4A and B) and the binding specifici-
ties of RepoMan-WT and RepoMan-M were similar (Fig-
ure 3C–E). This suggests that RepoMan binds to promot-
ers in a PP1-independent manner (Figure 8A), consistent
with recent observations that a RepoMan fragment lack-
ing the PP1-binding domain is still correctly targeted to hi-
stones (56,59). In contrast, PNUTS had numerous bind-
ing sites in common with PP1. Also, the binding specifici-
ties of PNUTS-WT and PNUTS-M were very similar but
PNUTS-WT had about three times more significant bind-
ing sites (Figure 3A, D and E). One interpretation of this
result is that PP1 somehow enhances the affinity of PNUTS
for an important subset of its promoter binding sites. How-
ever, the global binding of PNUTS to chromatin was not
affected by the knockdown of PP1 (Supplementary Figure
S5). Moreover, PNUTS-WT and PNUTS-M showed the
same binding to SNORD genes in ChIP experiments (Sup-
plementary Figure S9). Therefore, the distinct number of
chromatin-binding sites for PNUTS-WT and PNUTS-M
(Figure 8A) possibly stems from different expression levels
of the fusions. Finally, NIPP1 also shared many promoter-
binding sites with PP1 (Figure 4C and D), but the binding
specificities of NIPP1-WT and NIPP1-M were clearly dif-
ferent (Figure 3B, D and E), consistent with their embed-
ment in a distinct histone landscape. This indicates that PP1
regulates the promoter binding specificity of NIPP1 (Figure
8B), in agreement with recent findings that NIPP1 regulates
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the chromatin targeting of EZH2 in a PP1-dependent man-
ner (12,13).
Collectively, our data indicate that NIPP1, PNUTS and
RepoMan fulfill PP1-independent functions at promoters,
but that PP1 regulates the binding specificity of NIPP1. We
did not find any direct evidence for a role of PP1 in the pro-
moter targeting of PNUTS and RepoMan.
PP1-PNUTS at active promoters
Our DamID profiling identified a PP1-PNUTS holoen-
zyme that is associated with elongating RNA pol II at
dozens of active promoters (Figure 5). This agrees with a re-
cent report showing that PP1-PNUTS regulates RNA pol
II mediated transcription in Drosophila through dephos-
phorylation of the CTD domain of the largest subunit (10).
PNUTS was only mapped to about 4% of the RNA-pol II-
pS2 regulated promoters. This indicates that the promoter
binding of PNUTS is limited to a subset of RNA-pol II
regulated genes and/or that its binding to some promot-
ers is too transient to be detected by DamID. In any case,
in view of the large overlap between the promoter binding
sites of PNUTS-WT and PNUTS-M (79%), it seems un-
likely that this low percentage stems from non-saturation
of the DamID profiling. Intriguingly, PP1-PNUTS was
enriched at the promoters of gene clusters that encode hi-
stones or snoRNAs (Figure 6B and C), which are gener-
ated from primary transcripts that do not undergo 3′ end
polyadenylation. This leads to the enticing hypothesis that
PP1-PNUTS functions in the uncoupling of the cleavage
and polyadenylation steps of 3′ RNA end-processing. Ac-
cordingly, PP1 has already been shown to be implicated in
3′ RNA-processing (60,61), and PNUTS is a component of
a complex that regulates the processing of 3′ ends of RNA
(61). We have confirmed by ChIP analysis that PNUTS is
associated with SNORD genes (Supplementary Figure S9).
Also, we have found that the expression of the SNORD and
HIST1H3D genes is oppositely affected by the knockdown
of PNUTS and PP1 (Figure 7A and B), indicating that
PP1 downregulates the transcriptional activation of these
genes by PNUTS.
In conclusion, we have successfully used the DamID ap-
proach to map promoter-binding sites of the PP1 isoforms
and three nuclear PIPs in unperturbed, non-synchronized
HeLa cells. The data disclosed an unexpected PP1 isoform
binding specificity and showed that only a quarter of the
promoter binding is mediated by NIPP1, PNUTS or Re-
poMan. Our data also revealed that PP1 autoregulates its
own chromatin targeting by affecting the promoter binding
specificity of NIPP1.
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Supplementary Data are available at NAR Online.
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